Final Report on the Safety Assessment of Human and Animal Placental and Umbilical Extracts in Cosmetics

    Bindu R. Nair, Amy Elmore
    TLDR The safety of placental and umbilical extracts in cosmetics is uncertain, requiring more research.
    The report assessed the safety of various human and animal placental and umbilical extracts used in cosmetics. It found that human-derived ingredients, except for Human Placental Protein, were prohibited in the EU due to disease transmission concerns. Animal-derived placental proteins, hydrolyzed proteins, lipids, and enzymes were in use, but no current uses of umbilical extracts were reported. Most data indicated potential estrogenic or biological activity, but one clinical study showed no irritant reaction. The report concluded that available data were insufficient to ensure safety, recommending further studies on skin sensitization, toxicity, photosensitization, genotoxicity, and ocular toxicity. It emphasized that cosmetic ingredients should not have metabolic/endocrine activity and must be free of pathogens.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 787 results

      community This guy claims stem cells fixed his balding

      in Is this regrowth?  301 upvotes 10 months ago
      A man who claimed to have regrown his hair using stem cell treatment, sparking a debate about its effectiveness and cost. Some users suggested he might be using other treatments or substances, while others shared their own experiences with stem cell therapy for hair loss.

      community Which mesotherapy should I choose?

      in Research/Science  1 upvotes 5 months ago
      A user is considering adding PRP and mesotherapy to their hair loss treatment and is deciding between two options: Promoitalia, which contains Phosphatidic acid, Riboflavin, and Superoxide dismutase, and the more expensive Melsmon, a human placenta derivative. They seek advice on which option to choose based on effectiveness and scientific backing.

      community Verteporfin day 119 update - donor hair regeneration human trial

      in Research/Science  147 upvotes 1 year ago
      A human trial of verteporfin, a drug that can inhibit wound healing by scarring and promote regeneration of original tissue and hair follicles to provide an unlimited source for hair transplants; people discussed the potential of this drug and how it could be rolled out in mainstream with more doctors getting on board.